BackIGC Pharma Overview

IGC Pharma Intangible Assets

Latest intangible assets for IGC: $5.5M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$5.51M
175.76% YoYΔ $3.51M vs prior year quarter

Peer trimmed avg / median

Loading

IGC Pharma Intangible Assets History

Loading

IGC Pharma vs. peers: Intangible Assets Comparison

Loading

IGC Pharma Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

IGC Pharma (IGC) FAQ

As of the most recent data (June 2026), IGC shows a intangible assets of $5.5M. That compares with $2M in the prior-year period — up 175.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IGC's intangible assets is now $5.5M (was $2M) — a 175.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether IGC Pharma is outperforming or lagging.

Tracking IGC's intangible assets over time shows whether IGC Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $5.5M That compares with $2M in the prior-year period — up 175.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has IGC Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $5.5M) with ownership activity and broader fundamentals.

IGC Pharma's intangible assets is $5.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.